Cargando…
_version_ 1784571627117215744
author Dooling, Kathleen
Gargano, Julia W.
Moulia, Danielle
Wallace, Megan
Rosenblum, Hannah G.
Blain, Amy E.
Hadler, Stephen C.
Plumb, Ian D.
Moline, Heidi
Gerstein, Jack
Collins, Jennifer P.
Godfrey, Monica
Campos-Outcalt, Doug
Morgan, Rebecca L.
Brooks, Oliver
Talbot, H. Keipp
Lee, Grace M.
Daley, Matthew F.
Oliver, Sara E.
author_facet Dooling, Kathleen
Gargano, Julia W.
Moulia, Danielle
Wallace, Megan
Rosenblum, Hannah G.
Blain, Amy E.
Hadler, Stephen C.
Plumb, Ian D.
Moline, Heidi
Gerstein, Jack
Collins, Jennifer P.
Godfrey, Monica
Campos-Outcalt, Doug
Morgan, Rebecca L.
Brooks, Oliver
Talbot, H. Keipp
Lee, Grace M.
Daley, Matthew F.
Oliver, Sara E.
author_sort Dooling, Kathleen
collection PubMed
description
format Online
Article
Text
id pubmed-8459897
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-84598972021-10-07 Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021 Dooling, Kathleen Gargano, Julia W. Moulia, Danielle Wallace, Megan Rosenblum, Hannah G. Blain, Amy E. Hadler, Stephen C. Plumb, Ian D. Moline, Heidi Gerstein, Jack Collins, Jennifer P. Godfrey, Monica Campos-Outcalt, Doug Morgan, Rebecca L. Brooks, Oliver Talbot, H. Keipp Lee, Grace M. Daley, Matthew F. Oliver, Sara E. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2021-09-24 /pmc/articles/PMC8459897/ /pubmed/34555007 http://dx.doi.org/10.15585/mmwr.mm7038e2 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Dooling, Kathleen
Gargano, Julia W.
Moulia, Danielle
Wallace, Megan
Rosenblum, Hannah G.
Blain, Amy E.
Hadler, Stephen C.
Plumb, Ian D.
Moline, Heidi
Gerstein, Jack
Collins, Jennifer P.
Godfrey, Monica
Campos-Outcalt, Doug
Morgan, Rebecca L.
Brooks, Oliver
Talbot, H. Keipp
Lee, Grace M.
Daley, Matthew F.
Oliver, Sara E.
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
title Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
title_full Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
title_fullStr Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
title_full_unstemmed Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
title_short Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
title_sort use of pfizer-biontech covid-19 vaccine in persons aged ≥16 years: recommendations of the advisory committee on immunization practices — united states, september 2021
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459897/
https://www.ncbi.nlm.nih.gov/pubmed/34555007
http://dx.doi.org/10.15585/mmwr.mm7038e2
work_keys_str_mv AT doolingkathleen useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT garganojuliaw useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT mouliadanielle useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT wallacemegan useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT rosenblumhannahg useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT blainamye useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT hadlerstephenc useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT plumbiand useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT molineheidi useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT gersteinjack useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT collinsjenniferp useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT godfreymonica useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT camposoutcaltdoug useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT morganrebeccal useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT brooksoliver useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT talbothkeipp useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT leegracem useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT daleymatthewf useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021
AT oliversarae useofpfizerbiontechcovid19vaccineinpersonsaged16yearsrecommendationsoftheadvisorycommitteeonimmunizationpracticesunitedstatesseptember2021